Literature DB >> 11337944

Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese.

K Kumagai1, K Hiyama, S Ishioka, H Sato, Y Yamanishi, H L McLeod, F Konishi, H Maeda, M Yamakido.   

Abstract

Polymorphisms at three loci in the thiopurine methyltransferase (TPMT) gene are known to be responsible for azathioprine and 6-mercaptopurine (6MP) toxicity. Among them, only TPMT*3C variant allele with A719G mutation was found in 15/522 (2.9%; 17/1044 alleles; 1.6%) Japanese individuals including two homozygotes. The allele frequency was different from that in Caucasians, and investigation of TPMT polymorphisms with consideration of ethnic differences before administration of azathioprine or 6MP may provide clinically useful information.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337944     DOI: 10.1097/00008571-200104000-00012

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  25 in total

1.  Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia.

Authors:  Azza A G Tantawy; Fatma S E Ebeid; Amira A M Adly; Eman El-Ghoroury; Mai Mostafa
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

2.  Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia.

Authors:  Y Tanaka; H Nakadate; K Kondoh; K Nakamura; K Koh; A Manabe
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

3.  Thiopurine S-methyltransferase genetic polymorphism in the Thai population.

Authors:  Somrudee Srimartpirom; Wongwiwat Tassaneeyakul; Veerapol Kukongviriyapan; Wichittra Tassaneeyakul
Journal:  Br J Clin Pharmacol       Date:  2004-07       Impact factor: 4.335

4.  Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment.

Authors:  Kan Uchiyama; Makoto Nakamura; Takahiro Kubota; Tateki Yamane; Kiyotaka Fujise; Hisao Tajiri
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

5.  A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia.

Authors:  Suk-Kyun Yang; Myunghee Hong; Jiwon Baek; Hyunchul Choi; Wanting Zhao; Yusun Jung; Talin Haritunians; Byong Duk Ye; Kyung-Jo Kim; Sang Hyoung Park; Soo-Kyung Park; Dong-Hoon Yang; Marla Dubinsky; Inchul Lee; Dermot P B McGovern; Jianjun Liu; Kyuyoung Song
Journal:  Nat Genet       Date:  2014-08-10       Impact factor: 38.330

6.  TPMT genetic variations in populations of the Russian Federation.

Authors:  Elena V Samochatova; Natalia V Chupova; Anastassia Rudneva; Olga Makarova; Tatyana V Nasedkina; Olga E Fedorova; Andrei S Glotov; Zh Kozhekbaeva; Olga A Maiorova; Alexander G Roumyantsev; Eugene Y Krynetski; Natalia F Krynetskaia; William E Evans; Raul C Ribeiro
Journal:  Pediatr Blood Cancer       Date:  2009-02       Impact factor: 3.167

7.  Analysis of thiopurine S-methyltransferase phenotype-genotype in a Tunisian population with Crohn's disease.

Authors:  Lynda Ben Salah; Mouna Belkhiria el Haj Amor; Chahra Chbili; Saida Khlifi; Neila Fathallah; Iheb Bougmiza; Elhem Ben Jazia; Nicole Houdret; Chaker Ben Salem; Saad Saguem
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-04       Impact factor: 2.441

8.  Successful azathioprine treatment with metabolite monitoring in a pediatric inflammatory bowel disease patient homozygous for TPMT*3C.

Authors:  Mi-Na Lee; Hye In Woo; Yoo Min Lee; Ben Kang; Jong-Won Kim; Yon Ho Choe; Soo-Youn Lee
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

9.  NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia.

Authors:  D-C Liang; C-P Yang; H-C Liu; T-H Jaing; S-H Chen; I-J Hung; T-C Yeh; T-H Lin; C-L Lai; C-Y Lai; L-Y Shih
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

Review 10.  Pharmacogenomics: marshalling the human genome to individualise drug therapy.

Authors:  W E Evans
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.